Wendy C. Moore, MD, Michael D. Evans, MS, Eugene R

Slides:



Advertisements
Similar presentations
Buffering airway acid decreases exhaled nitric oxide in asthma Benjamin Gaston, MD, Robin Kelly, RN, Peter Urban, RN, Lei Liu, PhD, Edward M. Henderson,
Advertisements

Genome-wide association study identifies TH1 pathway genes associated with lung function in asthmatic patients  Xingnan Li, PhD, MS, Gregory A. Hawkins,
Peter Vadas, MD, PhD, Boris Perelman, PhD, Gary Liss, MD, MS 
Wei Wu, PhD, Eugene Bleecker, MD, Wendy Moore, MD, William W
Internet-Based Monitoring in the Severe Asthma Research Program Identifies a Subgroup of Patients With Labile Asthma Control  Kelly Wong-McGrath, MS,
Risk of an asthma exacerbation after bariatric surgery in adults
Asthma morbidity among inner-city adolescents receiving guidelines-based therapy: Role of predictors in the setting of high adherence  Rebecca S. Gruchalla,
Anne M. Fitzpatrick, PhD, MSCR, W. Gerald Teague, MD 
Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes  Annette T. Hastie, PhD, Wendy C. Moore,
Ventilation defect percent in helium-3 magnetic resonance imaging as a biomarker of severe outcomes in asthma  David G. Mummy, MS, Stanley J. Kruger,
Genome-wide association study identifies TH1 pathway genes associated with lung function in asthmatic patients  Xingnan Li, PhD, MS, Gregory A. Hawkins,
Stephen P. Peters, MD, PhD, Eugene R. Bleecker, MD, Susan J
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Michael E. Wechsler, MD, Michel Laviolette, MD, Adalberto S
Dennis K. Ledford, MD, Sally Wenzel, MD 
Obstructive Sleep Apnea Risk, Asthma Burden, and Lower Airway Inflammation in Adults in the Severe Asthma Research Program (SARP) II  Mihaela Teodorescu,
W. Gerald Teague, MD, Brenda R. Phillips, MS, John V
Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study  John M. Brehm, MD, MPH, Brooke Schuemann, BS,
Is 9 more than 2 also in allergic airway inflammation?
Badrul A. Chowdhury, MD, PhD 
Serum periostin is associated with type 2 immunity in severe asthma
Vaccination of patients with mild and severe asthma with a 2009 pandemic H1N1 influenza virus vaccine  William W. Busse, MD, Stephen P. Peters, MD, PhD,
Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J
IL-4 receptor polymorphisms predict reduction in asthma exacerbations during response to an anti–IL-4 receptor α antagonist  Rebecca E. Slager, PhD, MS,
Allergy testing in predicting outcome of open food challenge to peanut
Safety and efficacy of the prostaglandin D2 receptor antagonist AMG 853 in asthmatic patients  William W. Busse, MD, Sally E. Wenzel, MD, Eli O. Meltzer,
Physician needs in health informatics: Just ask the docs
Peter M. Wolfgram, MD, David B. Allen, MD 
William J. Calhoun, MD, Tmirah Haselkorn, PhD, Dave P
Jewlya Lynn, PhD, Sophie Oppenheimer, MS, MPH, Lorena Zimmer, MA 
Genome-wide ancestry association testing identifies a common European variant on 6q14.1 as a risk factor for asthma in African American subjects  Dara.
Ronald L. Sorkness, PhD, Edward M
Reply Journal of Allergy and Clinical Immunology
Phillip Lieberman, MD, Michael Tankersley, MD 
High eosinophil count: A potential biomarker for assessing successful omalizumab treatment effects  William Busse, MD, Sheldon Spector, MD, Karin Rosén,
Atopic dermatitis: A practice parameter update 2012
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management  Scott H. Sicherer, MD, Hugh A. Sampson, MD  Journal.
Peter Vadas, MD, PhD, Boris Perelman, PhD, Gary Liss, MD, MS 
Claus Bachert, MD, PhD, Cezmi A. Akdis, MD 
Update on the role of prostaglandins in allergic lung inflammation: Separating friends from foes, harder than you might think  Martin L. Moore, PhD, R.
Lisa G. Wood, PhD, Manohar L. Garg, PhD, Peter G. Gibson, MBBS 
What is an “eosinophilic phenotype” of asthma?
Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program  Wendy C. Moore, MD,
H. William Kelly, PharmD  Journal of Allergy and Clinical Immunology 
Autophagy: Nobel Prize 2016 and allergy and asthma research
Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment
House dust mite sublingual immunotherapy: Results of a US trial
Geographic variability in childhood asthma prevalence in Chicago
Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe.
Racial differences in biologic predictors of severe asthma: Data from the Severe Asthma Research Program  Christy Gamble, DrPHc, MPH, Evelyn Talbott,
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Gregory A. Hawkins, PhD, Mac B. Robinson, PhD, Annette T
Asthma morbidity among inner-city adolescents receiving guidelines-based therapy: Role of predictors in the setting of high adherence  Rebecca S. Gruchalla,
Genome-wide association studies of asthma indicate opposite immunopathogenesis direction from autoimmune diseases  Xingnan Li, PhD, Elizabeth J. Ampleford,
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Jessica H. Savage, MD, MHS, Elizabeth C. Matsui, MD, MHS, Robert A
Severity assessment in asthma: An evolving concept
Managing asthma exacerbations in the emergency department: Summary of the National Asthma Education and Prevention Program Expert Panel Report 3 guidelines.
Macrolide antibiotics and asthma treatment
Vaccination of patients with mild and severe asthma with a 2009 pandemic H1N1 influenza virus vaccine  William W. Busse, MD, Stephen P. Peters, MD, PhD,
Asthma: The past, future, environment, and costs
Wei Wu, PhD, Eugene Bleecker, MD, Wendy Moore, MD, William W
Environmental factors and eosinophilic esophagitis
Safety and efficacy of repeated monthly carboplatin desensitization
Natural history of cow’s milk allergy
The influence of asthma control on the severity of virus-induced asthma exacerbations  David J. Jackson, MRCP, PhD, Maria-Belen Trujillo-Torralbo, BSc,
Heterogeneity of severe asthma in childhood: Confirmation by cluster analysis of children in the National Institutes of Health/National Heart, Lung, and.
Eli O. Meltzer, MD, William W. Busse, MD, Sally E
Modeling asthma exacerbations through lung function in children
Quantitative computed tomographic imaging–based clustering differentiates asthmatic subgroups with distinctive clinical phenotypes  Sanghun Choi, PhD,
Presentation transcript:

Safety of investigative bronchoscopy in the Severe Asthma Research Program  Wendy C. Moore, MD, Michael D. Evans, MS, Eugene R. Bleecker, MD, William W. Busse, MD, William J. Calhoun, MD, Mario Castro, MD, Kian Fan Chung, MD, Serpil C. Erzurum, MD, Douglas Curran-Everett, PhD, Raed A. Dweik, MD, Benjamin Gaston, MD, Mark Hew, MD, Elliot Israel, MD, Martin L. Mayse, MD, Rodolfo M. Pascual, MD, Stephen P. Peters, MD, PhD, Lori Silveira, MS, Sally E. Wenzel, MD, Nizar N. Jarjour, MD  Journal of Allergy and Clinical Immunology  Volume 128, Issue 2, Pages 328-336.e3 (August 2011) DOI: 10.1016/j.jaci.2011.02.042 Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Change in FEV1 after bronchoscopy in the 4 groups of subjects. Shown is the percent change in percent predicted FEV1 from the first FEV1 before albuterol administration to the lowest FEV1 after bronchoscopy. There was no statistically significant difference in the distribution of percent change in percent predicted FEV1 among the groups (P = .30). Journal of Allergy and Clinical Immunology 2011 128, 328-336.e3DOI: (10.1016/j.jaci.2011.02.042) Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 Change in FEV1 after bronchoscopy for individual subjects. There is a mild relationship (r = –0.21; P < .0001) between better baseline lung function and greater percent decrease in FEV1. The closed circles represent the subjects who had asthma exacerbations. The closed triangles are subjects who went to the ED with other complaints. Journal of Allergy and Clinical Immunology 2011 128, 328-336.e3DOI: (10.1016/j.jaci.2011.02.042) Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions